Taking meds before exposure cuts HIV risk for heterosexuals Heterosexuals who are HIV negative can significantly reduce their risk of infection by taking a daily dose of an antiviral drug, according to a new study by the Centers for Disease Control and Prevention.
The study, called TDF2, followed 1,200 uninfected heterosexual men and women between the ages of 18 and 39 years in Botswana, Africa. Study participants took a tablet containing tenofovir disoproxil fumarate and emitricitabine (TDF/FTC), whose brand name is Truvada, or a placebo. On average, patients were followed for a year although some were followed for about three and a half years. The risk of infection was reduced 63% overall, but for participants who actually got the drugs, that risk decreased by 78%.
Giving daily antiretroviral drugs to uninfected individuals to prevent the disease is called pre-exposure prophylaxis or PrEP. Previous studies have shown PrEP to be effective in reducing infection rates among the uninfected.
Dr. Kevin Fenton, director of the CDC's national Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, called the news a milestone. "It is clear we are not going to find one magic pill to solve the issue of HIV but by combining this approach with others we are beginning to get a better handle on combination packages. There is reason to be excited."
http://thechart.blogs.cnn.com/2011/07/13/taking-meds-before-exposure-cuts-hiv-risk-for-heterosexuals/?hpt=hp_t2What about HIV - Gay people?